This report describes the first study to use national data from the Pharmaceutical Benefits Scheme (PBS) to investigate the patterns of asthma medication use in Australia.

This report identifies the demographics and health-related characteristics that define people with asthma and that distinguish them from those who have never had asthma.

Two of the key challenges for the New Zealand health system are improving quality and reducing inequities in health. My plan was to develop and test a quality improvement intervention for primary care to help close the ethnic health gap for child asthma. To understand the overall context of quality improvement to improve ethnic equity...

This report provides a background to defining and measuring National Health Priority Area indicators for asthma. The issues surrounding the selection, operational definition and measurement of indicators for asthma are presented. The report incorporates the view of stakeholders who were consulted in the development process through workshops around Australia.

The prevalence of asthma is increasing in western countries. Over two million Australians suffer with asthma, and one in every four to five children will have some asthma symptoms at some stage.